Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|June 21, 2013
Enzyme-responsive supramolecular polymers by complexation of bis(p-sulfonatocalixarenes) with suberyl dicholine-based pseudorotaxaneDong-Sheng Guo, Tian-Xing Zhang, Yi-Xuan Wang, et al.Frontiers in Chemistry|August 5, 2021
Deep Cavitand Calixarene-Solubilized Fullerene as a Potential Photodynamic AgentTian-Xing Zhang, Juan-Juan Li, Hua-Bin Li, et al.Medical Oncology (Northwood, London, England)|March 27, 2025
Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathwayMan-Wei Hao, Tian-Xing Zhang, Dan Dong, et al.Organic & Biomolecular Chemistry|December 12, 2024
Se-S dynamic exchange reaction: a strategy of highly efficient S-S bond cleavage for synthesizing benzothiazole derivativesTian-Xing Zhang, Er-Wei Zhang, Wen-Yue Zhang, et al.Journal of Environmental Management|March 17, 2026
Green recyclable resin-supported sulfur ionic liquid for efficient CO2 cycloaddition to cyclic carbonatesJu Fang, Guoying Li, Xin Fang, et al.Advanced Materials (Deerfield Beach, Fla.)|May 28, 2020
A General Hypoxia-Responsive Molecular Container for Tumor-Targeted TherapyTian-Xing Zhang, Zhan-Zhan Zhang, Yu-Xin Yue, et al.Journal of Materials Chemistry. B|November 28, 2023
Calixarene-based cryoprotectants for ice recrystallization inhibition and cell cryopreservationBing Hu, Juan-Juan Li, Yan-Bin Ren, et al.JCI Insight|December 20, 2024
YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axisWang Yang, Ming Zhang, Tian-Xing Zhang, et al.Theranostics|January 6, 2022
A hypoxia-responsive supramolecular formulation for imaging-guided photothermal therapyTian-Xing Zhang, Xiaoxue Hou, Yong Kong, et al.Small (Weinheim an Der Bergstrasse, Germany)|February 1, 2021
Calixarene-Embedded Nanoparticles for Interference-Free Gene-Drug Combination Cancer TherapyQi Liu, Tian-Xing Zhang, Yadan Zheng, et al.Pageof 1